Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
GPR also known as EBI is a G i coupled
2020-08-08

GPR183 (also known as EBI2) is a Gαi-coupled seven-transmembrane chemotactic receptor. It is highly expressed on follicular B cells, CD4+ dendritic cells (DCs), and CD4+ T cells but is downregulated on germinal center (GC) SMIP004 in secondary lymphoid organs and controls cell migration to achieve e
-
While we previously demonstrated that
2020-08-07

While we previously demonstrated that TraG is inhibited by specific transglycosylase inhibitors and that enzymatic activity is strongly reduced upon mutation of the potential catalytic core (Arends et al., 2013), the enzymatic mechanism of both domains was not assigned. Here, by mass spectrometry an
-
br The major regulator of radiation sensitivity Tumor cell r
2020-08-07

The major regulator of radiation sensitivity Tumor cell resistance to radiation is a big issue for radiation therapy, and a major concern of radiation oncologist. Understanding the regulation mechanism of radiation sensitivity is still a research hotspot. Increased sensitivity to ionizing radiati
-
DNA ligase IV expression was also enhanced in DNR
2020-08-07

DNA ligase IV expression was also enhanced in DNR-resistant subclones (Fig. 1). KU80- and DNA ligase IV-deficient plants are reportedly sensitive to ionizing radiation [53]. The regulatory mechanism of DNA ligase IV has not been reported yet. Sp1 expression reduced by siRNA and Sp1 inhibitor suppres
-
br Oxidoreductase like MEM for prodrug activation
2020-08-06

Oxidoreductase-like MEM for prodrug activation Future outlook Although MEM-mediated prodrug activation has been performed by different MEMs and prodrugs, and their effectiveness have been proved in vivo, only a few types of MEMs or prodrugs have been explored in prodrug activation until now [2
-
eletriptan hydrobromide br Introduction Essential hypertensi
2020-08-06

Introduction Essential hypertension is a heterogeneous disorder, genetic and environmental factors are associated with its pathogenesis, and it is a risk factor for cardiovascular disease and mortality. Carotid bodies (CB) are peripheral chemoreceptors that are responsible for monitoring changes
-
br Acknowledgement br Introduction Human dihydroorotate dehy
2020-08-06

Acknowledgement Introduction Human dihydroorotate dehydrogenase (hDHODH), a flavin-dependent mitochondrial enzyme involved in de novo Spectinomycin dihydrochloride biosynthesis, is a validated therapeutic target for the treatment of autoimmune diseases such as rheumatoid arthritis and cancer
-
A range of therapies exists for the treatment
2020-08-06

A range of therapies exists for the treatment of inflammation-driven diseases, which can be summarized as non-steroidal anti-inflammatory drugs (NSAIDs), corticoids and steroidal-related drugs (Ward et al., 2008). Despite of these notable successes, there are still major unmet medical needs in the t
-
The recent approval of ipilumumab nivolumab and pembrolizuma
2020-08-06

The recent approval of ipilumumab, nivolumab and pembrolizumab based on durable responses in malignant melanoma patients in conjunction with a reasonable safety profile has led to great enthusiasm in the immunotherapy field [45••, 46]. One major obstacle limiting the efficacy of immune checkpoint in
-
From the same perspective previous studies by Sajdyk
2020-08-06

From the same perspective, previous studies by Sajdyk and colleagues (Sajdyk et al., 1999) and Spiga and colleagues (Spiga et al., 2006) have shown that the administration of CRF or urocortin 1 (a selective agonist for CRF1 and CRF2 receptors but with a higher affinity for the CRF1 receptor) into th
-
The CRF receptor binding affinities for the described compou
2020-08-06

The CRF receptor binding affinities for the described compounds are shown in . Compounds were tested in a CRF receptor binding titration assay using rat frontal uk5099 australia homogenate, in which inhibition of specific binding of [I]Tyr-ovine CRF by our test compounds was measured to determine t
-
In the case of fuel requirements glucose
2020-08-06

In the case of fuel requirements, glucose-6-phosphate can enter glycolysis which is a well defined sequence of reactions leading to energy production and to pyruvate as an intermediate carbohydrate metabolite. In the first step of glycolysis, glucose-6-phosphate is converted into fructose-6-phosphat
-
Centralised waste management has known to fail at scale
2020-08-06

Centralised waste management has known to fail at scale, largely because of the complexity while decentralised systems however run on smaller, but manageable scales [11]. The centralised waste disposal arrangements shift the waste management problem from the source of waste generation to waste dispo
-
According to Uba E consists of four
2020-08-06

According to [11], Uba1-E1 consists of four building blocks: first, the adenylation domains composed of two motifs (labeled IAD (1–169) and AAD (404–594), for “inactive” and “active” adenylation domain, respectively), the latter of which binds ATP and Ub; second, the catalytic cysteine half-domains,
-
br Significance Ubl post translational modifications are pot
2020-08-05

Significance Ubl post-translational modifications are potential targets for developing novel therapeutics for life-threatening diseases, such as c-Myc- and KRas-driven cancers that lack targeted therapy. However, only a few drugs are available to target these modifications. This lack of drugs hig
15886 records 809/1060 page Previous Next First page 上5页 806807808809810 下5页 Last page